Martin P. Schrama

Martin P. Schrama mschrama@lexblogauthors.com 609.895.7334 Martin P. Schrama is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group. Mr. Schrama has extensive experience prosecuting and defending class actions involving securities, employment and consumer fraud claims. Currently, Mr. Schrama is Co-lead Trial Counsel representing numerous plaintiffs in the mass tort environmental contamination case of In Re Bristol-Myers Squibb Environmental Contamination Litigation. Mr. Schrama is also supervisory counsel for numerous Stark & Stark Litigation Teams. Mr. Schrama has extensive experience litigating on both the trial and appellate levels of the federal and state courts of New Jersey and New York, as well as numerous other jurisdictions throughout the nation.

Posts by Martin P. Schrama

Billion Dollar Verdict in DePuy Pinnacle Hip Replacement Lawsuit

Posted in DePuy Pinnacle, Medical Devices

Huge Victory in Hip Replacement Lawsuit Despite multiple attempts by Johnson & Johnson (J&J) to delay and dismiss the third DePuy Pinnacle hip implant bellwether trial, the case moved forward with outstanding results. After 12 weeks of trial, which included 32 witnesses called and 1,346 total admitted exhibits, Jurors awarded the six plaintiffs more than… Continue Reading

Missouri Court Awards $70 Million in Johnson & Johnson Talcum Powder Lawsuit

Posted in Defective Drugs

Another talcum powder lawsuit has seen favorable results in Missouri. Unlike in New Jersey, where Multicounty Litigation (MCL) Judge Nelson C. Johnson rejected the science linking talc to ovarian cancer claims, a Missouri court again ruled in favor of the plaintiff—this time to the tune of $70 million. The plaintiff, Deborah Giannecchini of Modesto, California… Continue Reading

Class I Recall of Alere INRatio and INRatio2 PT/INR Monitoring Systems Due to Incorrect Test Results

Posted in Alere INRatio2, Medical Devices, Recalls

There has been a Class I recall of Alere INRatio and INRatio2 PT/INR monitoring devices manufactured by Alere Inc. These devices are used to monitor blood clotting time as measured by PT/INR values in people taking blood thinning medication, including warfarin (also known as Coumadin). A Class I recall, the most serious type of recall, is… Continue Reading

Third DePuy Bellwether Trial Goes Forward

Posted in DePuy Pinnacle, Medical Devices

The third bellwether trial in the DePuy Orthopedics Pinnacle Hip Implant Multidistrict Litigation (MDL) is set to commence in the United States District Court, Northern District of Texas. The last multiple plaintiff bellwether case resulted in $150 million dollar verdict, which was later reduced due to punitive damage caps in Texas. The DePuy Pinnacle lawsuits… Continue Reading

NJ’s Evolving Expert Opinion Standard and its Effect on Multicounty Mass Tort Litigation

Posted in Defective Drugs

On September 2, 2016, New Jersey Superior Court Judge Nelson Johnson issued an Order and Opinion barring Plaintiffs’ experts in the ongoing litigation involving claims against Johnson & Johnson, alleging ovarian cancer caused by the drug maker’s talc products. For those that follow Mass Tort litigation in New Jersey, that decision was significant, but not… Continue Reading

The BARD IVC Court’s Utilization of Case Management Plans and Case Management Orders to Guide and Control the Multidistrict Litigation

Posted in Inferior Vena Cava (IVC), Medical Devices

IVC filter lawsuits are on the rise. On August 17, 2015, the United States Judicial Panel on Multidistrict Litigation (“JPML”) consolidated the Bard IVC lawsuits, as part of a Multidistrict Litigation (“MDL”), in the United States District Court for the District of Arizona. Case Management Plans and Case Management Orders for this MDL are described… Continue Reading

The Cook IVC Court’s Utilization of Case Management Plans and Case Management Orders to Guide and Control the Multidistrict Litigation

Posted in Inferior Vena Cava (IVC), Medical Devices

IVC filter lawsuits are on the rise. On October 15, 2014, the United States Judicial Panel on Multidistrict Litigation (“JPML”) designated the Cook IVC Multidistrict Litigation (“MDL”) in the United States District Court for the Southern District of Indiana. That Court has issued multiple Case Management Plans and Case Management Orders to guide and control… Continue Reading

The Xarelto Court’s Utilization of Pretrial Orders and Case Management Orders to Guide and Control the Multidistrict Litigation

Posted in Defective Drugs, Xarelto

Since the United States Judicial Panel on Multidistrict Litigation (“JPML”) designated the Multidistrict Litigation (“MDL”) on December 17, 2014, the United States District Court for the Eastern District of Louisiana (“EDLA”) has issued numerous Pretrial Orders and Case Management Orders to guide and control the MDL. On December 17, 2014, the EDLA issued Pretrial Order… Continue Reading

Zofran Injuries Continue To Be Reported

Posted in Zofran

Zofran (ondansetron), manufactured by GlaxoSmithKline, is a member of a class of drugs known as 5-HT3 receptor antagonists, which work by blocking the actions of serotonin. Zofran was approved by the Food and Drug Administration (FDA) in January 1991, to treat chemotherapy-related nausea, and the approval was later expanded to treat postoperative nausea and vomiting. According… Continue Reading

Xarelto Allegedly Not Safer Than Warfarin

Posted in Defective Drugs, Xarelto

Xarelto is marketed as an anticoagulant prescribed to reduce the risk of stroke, deep-vein thrombosis and pulmonary embolism. It is manufactured in the United States by Bayer and Johnson & Johnson’s New Jersey-based division, Janssen Pharmaceuticals. Lawsuits have been filed nationwide based on claims that Xarelto is responsible for injuries in some individuals. Lawsuits allege… Continue Reading

Stryker Orthopaedics Announces Settlement of Rejuvenate and ABG II Hip Device Lawsuits

Posted in Medical Devices

Howmedica Osteonics Corp., a subsidiary of Stryker Corporation, has agreed to settle the litigation over its Rejuvenate Modular-Neck hip stem and ABG II Modular-Neck hip stem devices. As reported by ABC News, Stryker has agreed to pay $1.43 billion to settle approximately four thousand lawsuits that are currently pending in New Jersey state court and… Continue Reading

Endo International Settles Remaining Pelvic Mesh Cases for $400 Million

Posted in Transvaginal Mesh

Endo International Plc (“Endo”) has agreed to pay $400 million to resolve the remaining legal claims from women who allege that they were injured by the company’s transvaginal mesh devices. This settlement comes less than six months after Endo agreed to pay $830 million to settle other mesh lawsuits. The settlement will resolve more than… Continue Reading

Johnson & Johnson Loses First Ethicon Bellwether Trial

Posted in Transvaginal Mesh

As we have previously reported, plaintiffs have alleged that employees of Johnson & Johnson’s Ethicon unit, manufacturers of the Gynecare Prolift implant, mishandled documents related to the device. Plaintiffs recently asked the Department of Justice to launch an investigation into Ethicon’s handling of thousands of documents related to the device. Since then, other consumer advocacy… Continue Reading

C.R. Bard Pelvic Mesh Internal Memoranda Show Company Knew of Risks

Posted in Transvaginal Mesh

The litigation against manufacturers of pelvic mesh devices continues to increase nationwide. A pelvic mesh implant is a synthetic material implanted and tied to ligaments or bone to lift and support internal organs. The implants were introduced over a decade ago, and can serve as an alternative to a hysterectomy. Thousands of women, who were… Continue Reading

Vaginal Mesh Bellwether Dates Announced

Posted in Transvaginal Mesh

As we have previously advised, the vaginal mesh implant litigation continues to move forward nationwide. The next trial in the federal court litigation is scheduled for early December 2013, against C.R. Bard, Inc., one of the manufacturers of the mesh device. There are four other bellwether cases set for trial in 2014. A lawsuit involving… Continue Reading

Vaginal Mesh Trial Set for December 2013

Posted in Transvaginal Mesh

As we have previously advised, the vaginal mesh implant litigation continues to move forward nationwide. A mesh implant is a synthetic material implanted and tied to ligaments or bone to lift and support internal organs. The implants were introduced over a decade ago, and can serve as an alternative to a hysterectomy. Thousands of women,… Continue Reading

FDA Meets to Discuss Safety of Diabetes Medications

Posted in Byetta, Januvia/Janumet and Victoza, Defective Drugs

As we have previously reported, research has shown that several incretin mimetic pharmaceuticals, such as Byetta, Januvia/Janumet and Victoza, may cause substantial injury in Type II diabetes patients. Incretin mimetic drugs help regulate blood sugar by stimulating insulin production by the pancreas. Doctors have expressed concern about these drugs and their connection between pancreatitis, pancreatic… Continue Reading